Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?

  1. Sanmamed, N.
  2. Gómez-Rivas, J.
  3. Buchser, D.
  4. Montijano, M.
  5. Gómez-Aparicio, M.A.
  6. Duque-Santana, V.
  7. Torres, L.
  8. Zilli, T.
  9. Ost, P.
  10. Maldonado, A.
  11. López-Campos, F.
  12. Couñago, F.
Journal:
Clinical Genitourinary Cancer

ISSN: 1938-0682 1558-7673

Year of publication: 2024

Volume: 22

Issue: 1

Pages: 56-66

Type: Review

DOI: 10.1016/J.CLGC.2023.08.002 GOOGLE SCHOLAR